The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback